Godsey & Gibb Inc’s Guardant Health GH Stock Holding History

Godsey & Gibb Inc’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$179	Buy	+1	New	+$163	﹤0.01%	554

Other funds holding GH

Krilogy Financial St. Louis, Missouri $3.66B AUM 22.28% 1-Year Est. Return

MAG

MRA Advisory Group Parsippany, New Jersey $267M AUM 19.2% 1-Year Est. Return

Fiduciary Alliance Greenville, South Carolina $1.33B AUM 15.58% 1-Year Est. Return

FFAS

FIG Financial Advisory Services Oklahoma City, Oklahoma $165M AUM 16.79% 1-Year Est. Return

Avior Wealth Management Omaha, Nebraska $3.79B AUM 15.36% 1-Year Est. Return

Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

CPBTD

Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return

SAM

Seelaus Asset Management Chatham, New Jersey $136M AUM 34.83% 1-Year Est. Return

Godsey & Gibb Inc's GH Position: Q3 2026 in Review

Godsey & Gibb Inc opened a new position in Guardant Health (GH) in Q3 2026: 1 share worth $179. The stake represents ﹤0.01% of the portfolio and ranks #554 among its holdings.

41 funds tracked by Wall St. Rank hold GH as of Q3 2026.

Godsey & Gibb Inc held 1 share of Guardant Health worth $179 as of Q3 2026.
Guardant Health was a new Godsey & Gibb Inc position in Q3 2026.
Guardant Health made up ﹤0.01% of Godsey & Gibb Inc's portfolio in Q3 2026, its #554 holding.
41 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on Godsey & Gibb Inc's 13F filing for Q3 2026, filed 14 Oct 2026.